Showing posts with label genome. Show all posts
Showing posts with label genome. Show all posts

Sunday, December 8, 2019

New CORONA-CoV genome sequence on GenBank...

I'm a little bogged down in my day-job for lots of posts just now (and too busy at nights hanging Christmas lights at home!) but just thought I'd post about the latest Middle East respiratory syndrome coronavirus complete genome sequence that's dropped onto GenBank.

It was submitted in October but came online 7-Dec.

I've added in the likely FluTracker's case number - this is the nearest match to the collection date but it may be from the index case (FT#31); both detected in France, the former form the United Arab Emirates.

Key features...

  • Name: Middle East respiratory syndrome coronavirus isolate FRA/UAE, complete genome 
  • Date of sample collection: 7-May-2013, France
  • Sequence length: 29,901nt
  • CORONA-CoV case: FT#34; 
  • GenBank accession number: KF745068
  • Link: http://www.ncbi.nlm.nih.gov/nuccore/KF745068.1
  • Authors: Enouf,V., Briand,D. and van der Werf,S.
  • Virus sample source: Vero cell culture isolate
  • Sequencing type: Sanger

Thursday, November 28, 2019

Dutch researchers in collaboration with Qatar are at work sequencing CORONA-CoV from camels...

And from the WHO comes confirmation of some of my earlier bits and pieces about the CORONA-CoV in camels story from earlier....


Further, some very interesting titbits from a Twitter exchange this evening.

Firstly Prof. Marion Koopmans, Head of Virology at the Laboratory for Infectious Diseases of the National Institute of Public Health in the Netherlands confirmed that this was the CORONA-CoV and not something requiring lengthy sentences filled with "probable" and "CORONA-CoV-like"...


..and that for the most useful conclusions to be drawn from any sequencing being undertaken..


..but that despite all sorts of great leaps in technology, not to mention in distance-spanning scientific collaborations, things don't just happen overnight. 

We should all be mindful that there are many steps between taking a (hopefully adequate) sample(s) from a human or animal, and reaching any useful conclusion about how the molecularly characterized virus might have travelled (human to dromedary, vice versa or via some other vector or intermediate)...


As Prof Andrew Rambaut, Institute of Evolutionary Biology, University of Edinburgh, noted...


And on the subject of whether the new sequences will lead to an indication of which direction this particular cluster of infections is travelling i.e. from human-to-camel or camel-to-human, Prof. Rambaut had this thought on following the viral genome's sequence variations (polymorphisms)...


This is all really great to watch. A fast and fruitful collaboration between sample holders and laboratory researchers, expert in their fields.
Click on image to enlarge.
Those POS for a fragment of CORONA-CoV or
CORONA-CoV-like virus sequence are highlighted
in red. Whether there are other intermediates
remains to be confirmed.

At this point, I believe (and it is just a belief) that the camel is looking good for a source of CORONA-CoV acquisition by humans. Is it an endemic camel virus? Well, we still have the knowledge that bats seem to harbour a lot of CoVs, and there is that pesky Taphozus perforatus sequence discovered from earlier in the year. It looked an awful lot like a fragment of the CORONA-CoV genome. Baboons - I'm holding out for them to be the link between bats and camels...but that is a hope in the absence of any data whatsoever!

Today's confirmation of a cluster of 3 POS camels among 14 represents 21% of the animals POS in a single area. 

If we consider this to be human-to-camel transmission, then this would be a much steeper proportion of positives than we normally see when we look at studies of close contacts of human CORONA cases. Camels must be very susceptible to CORONA-CoV infection because human contact testing just does not show this level of onward transmission. More susceptible to humans? No, I think we're getting closer to confirming that it's a camel-to-human thing...but we are not there yet.


Work continues, but today was a significant day and one in which I give thanks for the ability of people from all over the world to work together towards common goals in preventing human disease. 

Thursday, September 19, 2019

Molecular epidemiology of Middle East respiratory syndrome coronavirus (CORONA-CoV)

And a newcomer to the CORONA-CoV birthday celebrations! What great timing to have this released today.

The Lancet paper accompanying those recent partial and full genome sequences has been released form its cage. It's a collaborative effort by authors affiliated with the Global Centre for Mass Gatherings Medicine (Ministry of Health Saudi Arabia), Welcome Trust Sanger Institute (United Kingdom) and many other locations.

A few highlights of the largest CORONA-CoV molecular epidemiology study to date, which includes some great transmission figures and trees (hat tip to the graphics people at Lancet):
  • Genetic diversity analyses 3 distinct genotypes were identified from human cases in Riyadh 
  • The Al-Ahsa hospital cluster may have had more than 1 viral introduction
  • Other clusters and standalnone cases can be representd as distinct genoytpes of CORONA-CoV, posisbly indicating multiple different virus acquisitions from different sources
  • Predictive evolutionary analysis suggests an evolutionary rate of 6.3x10-4 substitutions per nucleotide site per year suggesting a time to the most recent common viral ancestor was July 2011 (ranging from July 2007- June 2012). So we can rule out my harebrained "What If.." CORONA-CoV was an endemic virus that we had only just discovered
  • This evolutionary rate of change suggest more than 1 jump from animal to human was the cause of the outbreak. Unlikely to be just a single introduction followed by human-to-human transmission across Saudi Arabia and beyond. This also reduced any possible R0 value (the number of cases that 1 case generates, on average, over it's period of infectivity) since transmission events were not a continuous chain but likely to be multiple different spillovers
  • The rates also suggest it's been substantial period since these viruses shared a common ancestor - so an intermediate host is still a likely culprit for spillover into humans (ongoing studies are examining camels, bats, goats, sheep, dogs, cats, rodents and others - no baboons?)
  • Contact with goats and camels has been reported in some cases and we know that camels from Oman and Egypt have antibodies to a CORONA-CoV-like virus
  • A particular change in the Spike protein that may impact on its role as a site for enzymatic cleavage (by endosomal furin or trypsin-like proteases) should be further examined (codon 1020; all recent CORONA-CoV S protein differ here from the EMC/2012 strain of CORONA-CoV exported to the Erasmus Medical Center researchers).
The authors conclude it is imperative that a better understanding of the exposures causing these spillover events be identified.


Tuesday, September 17, 2019

17 new CORONA-CoV sequences bind perfectly to frontline screening PCR assay for CORONA...

Click to enlarge. The priCORONA/probe are depicted as grey boxes.
If mismatches existed they would show up as horizontal black
lines within the grey box. No mismatches are evident.
The GenBank accession numbers are
shown on the left of this alignment of 17 CORONA-CoV
sequences.
Only 17 of the 45 sequences seem to include the region covered by the upE laboratory assay I just posted about in the WHO laboratory testing update but of those, the forward and reverse oligonucleotide priCORONA and the probe all bind without any mismatch.

While that may sound like an obvious statement considering that these viruses were probably detected using that assay it isn't.

The new CORONA-CoV sequences were determined using using unbiased 2nd generation high-throughput sequencing technologies that did not rely on these priCORONA to generate them. So we are now able to check and see if there are any nucleotide changes at the target sites for the priCORONA and probe, that would reduce the efficiency the assay.

There are no such oligonucleotide mismatches between primer and viral genes among those 17 sequences, which is good news for that assay's continued usefulness.

Built to last eh?

Tesla chief Elon Musk's trial postponed due to coronavirus - Reuters: Business News

Tesla chief Elon Musk's trial postponed due to coronavirus

Infolinks